Pharmacokinetic Interaction Between Trospium With an Inhibitor of OCT1 and of P-gp in Subjects Genotyped for OCT1

Clinical trial NCT03011463 · COMPLETED

Trial details

NCT number: NCT03011463
Sponsor: Dr. R. Pfleger Chemische Fabrik GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics Inhibition Enzyme Drug Interaction Potentiation

Start date: 2016-11-01
Primary completion: 2017-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.